Are clinical trials safe?

Yes. Every study on QualifiedStudies is reviewed and approved by an Institutional Review Board (IRB) and conducted under FDA regulations. Research sites are HIPAA-covered entities, and you can withdraw at any time for any reason.

Do I get paid to participate in a clinical trial?

Most studies offer compensation for your time and travel. The amount varies by study length and visit schedule, and is disclosed up front before you enroll.

Is my health information kept private?

Yes. Your information is encrypted, never sold, and only shared with the specific research site you choose to apply to. Our handling of your data is governed by our Consumer Health Data Privacy Policy; the research sites you're matched with are HIPAA-covered entities.

How do I qualify for a clinical trial?

Take our free 60-second eligibility quiz. Enter your ZIP code, condition, and a few health details, and we'll match you with research sites near you that are actively enrolling participants.

Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia

NCT ID: NCT07495943
Registry status: Not yet recruiting
Study type: Interventional
Phase: Not applicable
Sponsor: Haydarpasa Numune Training and Research Hospital
Conditions: Fibromyalgia, Fibromyalgia Syndrome

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Official title: Effects of 2-Aticyto Complex and D-Ribose on Pain, Symptoms, and Clinical Course in Patients With Fibromyalgia Syndrome

Enrollment: 200 participants (Estimated).

What is being studied

Dietary supplement: 2-Aticyto Complex and D-ribose Oral Supplement
Other: Placebo syrup

Who may be eligible

Ages: 18 Years to 65 Years
Sex: All
Healthy volunteers accepted: No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Adults aged 18 to 65 years * Diagnosis of fibromyalgia syndrome according to the 2016 ACR criteria * Followed in a physical medicine and rehabilitation outpatient clinic for at least 1 year * Receiving pregabalin and/or duloxetine treatment for at least 3 months * Able to live independently in the community * Literate and able to record symptoms and responses * No cognitive dysfunction that would interfere with answering study questions * Able and willing to provide informed consent Exclusion Criteria: * Rheumatologic disease * Renal failure * Hepatic failure * Cardiovascular disease * Hypoglycemia or diabetes mellitus * Any neurologic disease (such as stroke, spinal cord injury, multiple sclerosis, or Parkinson's disease) * Known allergy or hypersensitivity to any active or excipient component of the study syrup * Use of any other dietary supplement or nutritional support product during the study period * Pregnancy or lactation * Active malignancy * Active infection * Severe psychiatric disease that may interfere with study participation or assessment * Refusal to participate or inability to provide informed consent

Study locations

5 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: Turkey (Türkiye)

Istanbul, Turkey (Türkiye): 1

Sample of listed locations

University of Health Sciences, Haydarpasa Numune Training and Research Hospital, Department of Physical Medicine and Rehabilitation — Istanbul, Istanbul, 34662, Turkey (Türkiye) — Site recruitment status not specified in the registry data
Erenkoy Physical Therapy and Rehabilitation Hospital, Department of Physical Medicine and Rehabilitation — Istanbul, 34732, Turkey (Türkiye) — Site recruitment status not specified in the registry data
University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Department of Physical Medicine and Rehabilitation — Istanbul, 34480, Turkey (Türkiye) — Site recruitment status not specified in the registry data
University of Health Sciences, Fatih Sultan Mehmet Training and Research Hospital, Department of Physical Medicine and Rehabilitation — Istanbul, 34752, Turkey (Türkiye) — Site recruitment status not specified in the registry data
University of Health Sciences, Sultan Abdulhamid Han Training and Research Hospital, Department of Physical Medicine and Rehabilitation — Istanbul, 34668, Turkey (Türkiye) — Site recruitment status not specified in the registry data

Study details

Start date: October 4, 2026
Primary completion date: May 4, 2027
Completion date: May 4, 2027
First posted: March 27, 2026
Collaborators: Almediko Saglik Urunleri Turizm Gida Sanayi ve Ticaret Limited Sirketi

Source and update information

Source: ClinicalTrials.gov
NCT ID: NCT07495943
Registry last updated: September 21, 2026
QualifiedStudies registry data refreshed: September 28, 2026
QualifiedStudies record fetched: September 28, 2026

View NCT07495943 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Clinical trial FAQ